NCT02360631View on ClinicalTrials.gov

Advancing Tobacco Use Treatment for African American Smokers

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

July 29, 2015

Primary Completion Date

July 12, 2018

Study Completion Date

July 12, 2018

Conditions
Smoking Cessation
Interventions
DRUG

Chantix

A drug used to treat nicotine addiction.Chantix is approved by the FDA to be given to help people quit smoking.

DRUG

Placebo

Health education counseling will be provided to all participants.

Trial Locations (2)

64130

Swope Health Central, Kansas City

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Lisa Sanderson Cox, PhD

OTHER

NCT02360631 - Advancing Tobacco Use Treatment for African American Smokers | Biotech Hunter | Biotech Hunter